权益分类	功能权益	普通用户	{{item.name}}会员
{{category.name}}	{{benefitItem.name}}

Doctoral Dissertation Research: Biomedical Practices and New Medical Pharmaceuticals in Germany

博士论文研究：德国的生物医学实践和新型医用药物

基本信息

批准号：
1155340
负责人：
Judith Farquhar
金额：
$ 1.32万
依托单位：
University of Chicago
依托单位国家：
美国
项目类别：
Standard Grant
财政年份：
2012
资助国家：
美国
起止时间：
2012-05-01 至 2014-04-30
项目状态：
已结题

来源：
https://www.nsf.gov/awardsearch/showAward?AWD_ID=1155340&HistoricalAwards=false
关键词：
Doctoral Dissertation Research Biomedical Practices

项目摘要

Doctoral Dissertation Research: Biomedical Practices and New Medical Pharmaceuticals in GermanyThis project investigates the origins, meanings, and effects of new medical pharmaceuticals that can both treat disease and address the functioning of healthy individuals. Using interviews with biomedical professionals who deploy these new pharmaceuticals, and ethnographic observations, this research examines how the development and use of these pharmaceuticals are understood by biomedical professionals, who have historically been oriented toward assisting those who are ill rather than addressing biomedical issues in healthy people. Interviews and ethnographic research are also used to investigate how users learn about and attribute value to these new pharmaceuticals. This research contributes to social science theories of how human health and well-being are understood and evaluated by biomedical professional and scientists. It also contributes to social science theories of the sources of change in biomedical practices, by examining the role of new products in shaping assumptions, subjects, and personnel. Broader impacts of this research include new resources for programs intended to provide public information about new pharmaceuticals, and materials that can help in the formulation of policy responses and professional guidelines for biomedical professionals whose practices may be shaped by new orientations toward human well-being.

博士论文研究：德国的生物医学实践和新的医疗药物这个项目调查了既能治疗疾病又能解决健康个体功能的新的医疗药物的起源、意义和效果。利用对部署这些新药物的生物医学专业人员的采访和人种学观察，这项研究考察了生物医学专业人员如何理解这些药物的开发和使用，他们历史上一直致力于帮助那些生病的人，而不是解决健康人的生物医学问题。访谈和人种学研究也被用来调查用户如何了解这些新药物并赋予其价值。这项研究有助于社会科学理论，即生物医学专业人士和科学家如何理解和评估人类的健康和福祉。它还通过研究新产品在塑造假设、对象和人员方面的作用，为生物医学实践中的变化来源的社会科学理论做出贡献。这项研究的更广泛影响包括为旨在提供有关新药物的公共信息的项目提供新的资源，以及有助于为生物医学专业人员制定政策回应和专业指导方针的材料，这些专业人员的实践可能会受到人类福祉新取向的影响。